Bionomics Ltd - BNOX Enterprise Value-to-Sales Ratio

Public company logo of Bionomics Ltd (BNOX)

Bionomics Limited (BNOX) operates in a stable environment where the humanitarian status of biomedicine offsets external conflicts. The current enterprise value-to-revenue multiple on GURU.Markets reflects the asset's dynamics, and this metric equals . The company's foundation rests on patent protection for CNS ion channels, while growth is driven by BNC210 tests for anxiety without the side effects associated with benzodiazepines.

bionomics.com.au (BNOX): EV/Sales Multiple from 07/04/2022 to 11/20/2026

BNOX (Bionomics Ltd): analytical breakdowns and indicator data

Initial company analysis:Bionomics Ltd, BNOX
Original product of Bionomics Ltd.

This indicator compares the enterprise value (EV), including debt and cash, to annual sales, eliminating the impact of financial leverage on the valuation. By analyzing the EV/Revenue multiple, an investor assesses the capitalization efficiency of Bionomics Limited (BNOX), where steady demand for antidepressants makes the metric dependent on clinical trial success rather than economic cycles.